Patents Assigned to GRG GENE TECHNOLOGY SA
  • Compositions for the administration of APOA1 and dosages
    Patent number: 11382348
    Abstract: The present invention relates to new compositions for the oral administration of apolipoproteins in the dimeric or multimeric form, with specific dosage regimens for use in the treatment of atherosclerosis.
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: July 12, 2022
    Assignee: GRG GENE TECHNOLOGY SA
    Inventors: Roberto Giovannoni, Gabriele Romano, Nicola Fogher, Maria Rita Giuffre′, Mariateresa Pettinato, Serena Reggi
  • COMPOSITIONS FOR THE ADMINISTRATION OF APOA1 AND DOSAGES
    Publication number: 20190246677
    Abstract: The present invention relates to new compositions for the oral administration of apolipoproteins in the dimeric or multimeric form, with specific dosage regimens for use in the treatment of atherosclerosis.
    Type: Application
    Filed: July 31, 2017
    Publication date: August 15, 2019
    Applicant: GRG GENE TECHNOLOGY SA
    Inventors: Roberto GIOVANNONI, Gabriele ROMANO, Nicola FOGHER, Maria Rita GIUFFRE', Mariateresa PETTINATO, Serena REGGI